Table 1.
Gene1 | Primer sequence | Size | Acc (reference) | |
---|---|---|---|---|
SOD | GTGACCTCGGCAATGTGACT GCAGTGTGGTCCGGTAAGAG |
86 | NM_205064.1 | |
GPx | AAGAACTTCGGGCACCAGGA TGTACTGCGGGTTGGTCATC |
214 | NM_001277853.2 | |
HSP70 | CGTCAGTGCTGTGGACAAGAGTA CCTATCTCTGTTGGCTTCATCCT |
145 | NM_001006685 | |
HSP90 | GATCCCCAGACACATGCCAA CTCGGTAACTGCAGGACTGG |
105 | NM_001109785 | |
TLR2 | CGGTCATCTCAGCTACACCA GCATCGCATGAAAGACAGGC |
150 |
NM_204278 |
|
TLR4 | CCACACACCTGCCTACATGAA GGATGGCAAGAGGACATATCAAA |
63 |
NM_001030693 |
|
IL-1β | CCCGCCTTCCGCTACA CACGAAGCACTTCTGGTTGATG |
66 |
NM_204524.1 |
|
IL-4 | GCTCTCAGTGCCGCTGATG GAAACCTCTCCCTGGATGTCAT |
60 | NM_001007079.1 | |
IL-10 | CGCTGTCACCGCTTCTTCA CGTCTCCTTGATCTGCTTGATG |
63 | NM_001004414.2 | |
IL-17A | AGCTGGACCACAGCGTCAAC GGCGGAGGACGAGGATCT |
57 | NM_204460.1 | |
IL-22 | CTTCTCACCAGCCCCCTACCTCCA GCTGACCGATGAGTCTGTTGTCAGTG |
175 | NM_001199614.1 | |
TNFα | CCCATCCCTGGTCCGTAAC ATACGAAGTAAAGGCCGTCCC |
77 | MF000729.1 | |
iNOS | CCTGTACTGAAGGTGGCTATTGG AGGCCTGTGAGAGTGTGCAA |
66 | NM_204961.1 | |
IFNγ | AGTCAAAGCCGCACATCAAAC TTCACCTTCTTCACGCCATCA |
82 | NM_205149.1 | |
Occludin | CCGTAACCCCGAGTTGGAT ATTGAGGCGGTCGTTGATG |
214 | NM_205128.1 | |
ZO-1 | GGAGTACGAGCAGTCAACATAC GAGGCGCACGATCTTCATAA |
101 | XM_413773 | |
mTOR | CATGTCAGGCACTGTGTCTATTCTC CTTTCGCCCTTGTTTCTTCACT |
77 | XM_417614.6 | |
GAPDH | CCTAGGATACACAGAGGACCAGGTT GGTGGAGGAATGGCTGTCA |
64 | NM_204305 |
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; GPx: Glutathione peroxidase; HSP: Heat shock protein; IL: Interleukin; iNOS: Inducible nitric oxide synthase; IFNγ: Interferon gamma; SOD: Superoxide dismutase; TNFα: Tumor necrosis factor alpha; TLR: Toll Like Receptor; mTOR: Mechanistic target of rapamycin; ZO: Zonula occluden. For each gene, the primer sequence for forward (F) and reverse (R) (5ʹ-3ʹ) primers, the amplicon size (bp) and the NCBI Accession number (Acc) used for the primer design are listed.